<PAGE>
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12B-25
NOTIFICATION OF LATE FILING
SEC FILE NUMBER
1-4530
CUSIP NUMBER
046357 20 8
(CHECK ONE):
[X] Form 10-K and Form 10-KSB [ ] Form 20-F [ ] Form 11-K
[ ] Form 10-Q and Form 10-QSB
[ ] Form N-SAR
For Period Ended: March 31, 1997
--------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
- -------------------------------------------------------------------------------
READ ATTACHED INSTRUCTION SHEET BEFORE PREPARING FORM. PLEASE
PRINT OR TYPE. Nothing in this form shall be construed to imply
that the Commission has verified any information contained
herein.
- -------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
- -------------------------------------------------------------------------------
Full Name of Registrant
Former Name if Applicable
ASTREX, INC.
- -------------------------------------------------------------------------------
Address of Principal Executive Office (STREET AND NUMBER)
205 EXPRESS STREET
- -------------------------------------------------------------------------------
PLAINVIEW NY 11803
- -------------------------------------------------------------------------------
<PAGE>
PART II - RULES 12B-25 (B) AND ( C)
- -------------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate).
[X] (a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable effort or
expense.
[X] (b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or option
thereof will be filed on or before the fifteenth calendar day
following the prescribed due date; and (Amended in Release No.
34-26589, effective April 12, 1989, 54 F.R. 10306.
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25 (c) has been attached if applicable.
- -------------------------------------------------------------------------------
PART III - NARRATIVE
- -------------------------------------------------------------------------------
State below in reasonable detail the reasons why Form 10-K and Form 10-KSB,
20-F, 11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or portion
thereof could not be filed within the prescribed period.
Due to a member of the Board (also in-house counsel), being ill, and the
re-negotiating of a new bank line which should be incorporated into the
footnotes of the Form 10-KSB.
(Attach Extra Sheets if Needed)
- -------------------------------------------------------------------------------
PART IV - OTHER INFORMATION
- -------------------------------------------------------------------------------
(1) Name and telephone number of person to contact in regard to this
notification,
Irene Marcic 516 433-1700 ext. 204
- -------------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d)
of the Securities Exchange Act of 1934 or section 30 of the
Investment Company Act of 1940 during the preceding 12 months or
for such shorter period that the registrant was required to file
such report(s) been filed? If the answer is no, identify
report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the
subject report or portion thereof?
[ ] Yes [X] No
<PAGE>
If so; attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
Astrex, Inc.
----------------------------------------------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date : June 27, 1997 By : Irene Marcic, Secretary
------------- ------------------------
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other that an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
- -------------------------------------------------------------------------------
